The Infertility Treatment Market size is USD 2.3 Bn in 2026.
The Infertility Treatment Market is projected to grow at a CAGR of 8% by 2033.
The market growth is driven by declining fertility rates, delayed childbirth, rising infertility prevalence, and increasing adoption of ART procedures.
Asia Pacific is a dominating region for the infertility treatment market.
Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, Ferring Pharmaceuticals, and The Cooper Companies Inc. are leading players in the infertility treatment market.